Search research articles
Contact Us
Filters
Showing results (171-180 of 307) with videos related to
Page
of 31
Sort By:
Swiss Medical Weekly
|
August 4, 2017
Therapy-related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome
Christian Weisstanner, Livio Mordasini, George N Thalmann, et al.
The Journal of Urology
|
June 17, 2014
FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases
Rafal Turo, Patricia Harnden, Helene Thygesen, et al.
Virchows Archiv : an International Journal of Pathology
|
March 27, 2015
Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
J Tschui, E Vassella, N Bandi, et al.
Brachytherapy
|
November 29, 2008
Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy
Pirus Ghadjar, Tamara Keller, Cyrill A Rentsch, et al.
European Urology
|
August 22, 2007
The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study
Agostino Mattei, Frank G Fuechsel, Nivedita Bhatta Dhar, et al.
European Urology
|
November 3, 2009
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder
Beat Roth, Michael P Wissmeyer, Pascal Zehnder, et al.
Cold Spring Harbor Perspectives in Medicine
|
April 18, 2018
Metastases in Prostate Cancer
Federico La Manna, Sofia Karkampouna, Eugenio Zoni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 27, 2009
Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer
Pirus Ghadjar, Oscar Matzinger, Bernhard Isaak, et al.
European Urology
|
February 7, 2016
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature
Laura Evangelista, Alberto Briganti, Stefano Fanti, et al.
Oncotarget
|
July 11, 2018
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma
Janine Hensel, Antoinette Wetterwald, Ramzi Temanni, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 307) with videos related to
Sort By:
Page
of 31
Swiss Medical Weekly
|
August 4, 2017
Therapy-related longitudinal brain perfusion changes in patients with chronic pelvic pain syndrome
Christian Weisstanner, Livio Mordasini, George N Thalmann, et al.
The Journal of Urology
|
June 17, 2014
FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases
Rafal Turo, Patricia Harnden, Helene Thygesen, et al.
Virchows Archiv : an International Journal of Pathology
|
March 27, 2015
Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
J Tschui, E Vassella, N Bandi, et al.
Brachytherapy
|
November 29, 2008
Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy
Pirus Ghadjar, Tamara Keller, Cyrill A Rentsch, et al.
European Urology
|
August 22, 2007
The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study
Agostino Mattei, Frank G Fuechsel, Nivedita Bhatta Dhar, et al.
European Urology
|
November 3, 2009
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder
Beat Roth, Michael P Wissmeyer, Pascal Zehnder, et al.
Cold Spring Harbor Perspectives in Medicine
|
April 18, 2018
Metastases in Prostate Cancer
Federico La Manna, Sofia Karkampouna, Eugenio Zoni, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 27, 2009
Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer
Pirus Ghadjar, Oscar Matzinger, Bernhard Isaak, et al.
European Urology
|
February 7, 2016
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature
Laura Evangelista, Alberto Briganti, Stefano Fanti, et al.
Oncotarget
|
July 11, 2018
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma
Janine Hensel, Antoinette Wetterwald, Ramzi Temanni, et al.
Page
of 31